Gene · 9170
Papers3,539
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,539
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development and Characterization of Potent Succinate Receptor Fluorescent Tracers. | J Med Chem | 2023 | 37318348 | PubTator, text mining | PubMed |
| FIBP is a prognostic biomarker and correlated with clinicalpathological characteristics and immune infiltrates in acute myeloid leukemia. | Discov Oncol | 2023 | 37310595 | PubTator, text mining | PubMed |
| Stimulation of the Hydroxycarboxylic Acid Receptor 2 With the Ketone Body 3-Hydroxybutyrate and Niacin in Patients With Chronic Heart Failure: Hemodynamic and Metabolic Effects. | J Am Heart Assoc | 2023 | 37301762 | PubTator, text mining | PubMed |
| A Unique Mode of Coenzyme A Binding to the Nucleotide Binding Pocket of Human Metastasis Suppressor NME1. | Int J Mol Sci | 2023 | 37298313 | PubTator, text mining | PubMed |
| Identification of Key Genes and Regulatory Pathways in Multiple Sclerosis Brain Samples: A Meta-Analysis of Micro-Array Datasets. | Int J Mol Sci | 2023 | 37298310 | PubTator, text mining | PubMed |
| Investigations on Primary Cilia of Nthy-ori 3-1 Cells upon Cysteine Cathepsin Inhibition or Thyrotropin Stimulation. | Int J Mol Sci | 2023 | 37298246 | PubTator, text mining | PubMed |
| A Novel Oncogenic Role of FDX1 in Human Melanoma Related to PD-L1 Immune Checkpoint. | Int J Mol Sci | 2023 | 37298135 | PubTator, text mining | PubMed |
| Identification of New Prognostic Genes and Construction of a Prognostic Model for Lung Adenocarcinoma. | Diagnostics (Basel) | 2023 | 37296766 | PubTator, text mining | PubMed |
| Differentiation, Transcriptomic Profiling, and Calcium Imaging of Human Hypothalamic Neurons. | Curr Protoc | 2023 | 37272700 | PubTator, text mining | PubMed |
| Systematic review: efficacy of therapies for cholestatic pruritus. | Ther Adv Gastroenterol | 2023 | 37255856 | PubTator, text mining | PubMed |
| Gintonin, a Panax ginseng-derived LPA receptor ligand, attenuates kainic acid-induced seizures and neuronal cell death in the hippocampus via anti-inflammatory and anti-oxidant activities. | J Ginseng Res | 2023 | 37252272 | PubTator, text mining | PubMed |
| Oral and fecal microbiota perturbance in cocaine users: Can rTMS-induced cocaine abstinence support eubiosis restoration? | iScience | 2023 | 37250301 | PubTator, text mining | PubMed |
| Urinary Biomarkers in Monitoring the Progression and Treatment of Autosomal Dominant Polycystic Kidney Disease-The Promised Land? | Medicina (Kaunas) | 2023 | 37241147 | PubTator, text mining | PubMed |
| Environmental Pollution and the Risk of Developing Metabolic Disorders: Obesity and Diabetes. | Int J Mol Sci | 2023 | 37240215 | PubTator, text mining | PubMed |
| WGS Revealed Novel BBS5 Pathogenic Variants, Missed by WES, Causing Ciliary Structure and Function Defects. | Int J Mol Sci | 2023 | 37240074 | PubTator, text mining | PubMed |
| Phenotype of White Sika Deer Due to SCF Gene Structural Variation. | Genes (Basel) | 2023 | 37239395 | PubTator, text mining | PubMed |
| Phospholipases in Gliomas: Current Knowledge and Future Perspectives from Bench to Bedside. | Biomolecules | 2023 | 37238668 | PubTator, text mining | PubMed |
| Characterization and translational development of IOA-289, a novel autotaxin inhibitor for the treatment of solid tumors. | Immunooncol Technol | 2023 | 37234285 | PubTator, text mining | PubMed |
| Strong correlation between F2RL3 in the blood and osteoarthritis based on a retrospective cohort study. | Medicine (Baltimore) | 2023 | 37233402 | PubTator, text mining | PubMed |
| Combined inhibition of EZH2 and the autotaxin-LPA-LPA2 axis exerts synergistic antitumor effects on colon cancer cells. | Cancer Lett | 2023 | 37230222 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9170/papers?page=17